Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Magnesium sulfate 50% (magnesium 2mmol/ml) solution for injection 5ml ampoules (Martindale Pharmaceuticals Ltd) |
| BNF code | 0905013N0AAANAN |
| Virtual Medicinal Product | Magnesium sulfate 50% (magnesium 2mmol/ml) solution for injection 5ml ampoules |
| Name | Magnesium sulfate 50% (magnesium 2mmol/ml) solution for injection 5ml ampoules |
| Abbreviated name | Magnesium sulfate 50% (magnesium 2mmol/ml) inj 5ml ampoules |
| Date of name applicability | 6 Nov 2013 |
| Previous name | Magnesium sulfate 50% solution for injection 5ml ampoules |
| Supplier | Martindale Pharmaceuticals Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
| Licensed Route | |
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Magnesium sulfate 50% (magnesium 2mmol/ml) solution for injection 5ml ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.